153 related articles for article (PubMed ID: 22227582)
1. Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.
Li T; Liu Z; Hu X; Ma K; Zhou C
Biochim Biophys Acta; 2012 Feb; 1823(2):582-92. PubMed ID: 22227582
[TBL] [Abstract][Full Text] [Related]
2. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
Rolfe M; McLeod LE; Pratt PF; Proud CG
Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
[TBL] [Abstract][Full Text] [Related]
3. Na+/H+ exchanger isoform 1 induced cardiomyocyte hypertrophy involves activation of p90 ribosomal s6 kinase.
Jaballah M; Mohamed IA; Alemrayat B; Al-Sulaiti F; Mlih M; Mraiche F
PLoS One; 2015; 10(4):e0122230. PubMed ID: 25830299
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin-activated ERK/MAP kinase enhances GATA-4 acetylation via phosphorylation of serine 261 of GATA-4.
Jun JH; Shim JK; Ryoo HM; Kwak YL
J Cell Physiol; 2013 Jan; 228(1):190-7. PubMed ID: 22674427
[TBL] [Abstract][Full Text] [Related]
5. Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways.
Markou T; Hadzopoulou-Cladaras M; Lazou A
J Mol Cell Cardiol; 2004 Nov; 37(5):1001-11. PubMed ID: 15522277
[TBL] [Abstract][Full Text] [Related]
6. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
8. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition.
Chen S; Overberg K; Ghouse Z; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
Biomed Pharmacother; 2024 May; 174():116477. PubMed ID: 38522235
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.
Liang Q; Wiese RJ; Bueno OF; Dai YS; Markham BE; Molkentin JD
Mol Cell Biol; 2001 Nov; 21(21):7460-9. PubMed ID: 11585926
[TBL] [Abstract][Full Text] [Related]
11. p90(RSK)s mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes.
Zhang Z; Liu R; Townsend PA; Proud CG
J Mol Cell Cardiol; 2013 Jun; 59():139-47. PubMed ID: 23510923
[TBL] [Abstract][Full Text] [Related]
12. Phenylephrine and sustained acidosis activate the neonatal rat cardiomyocyte Na+/H+ exchanger through phosphorylation of amino acids Ser770 and Ser771.
Coccaro E; Karki P; Cojocaru C; Fliegel L
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H846-58. PubMed ID: 19542484
[TBL] [Abstract][Full Text] [Related]
13. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
14. Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.
Sawicka K; Pyronneau A; Chao M; Bennett MV; Zukin RS
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6290-E6297. PubMed ID: 27663742
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
[TBL] [Abstract][Full Text] [Related]
16. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
[TBL] [Abstract][Full Text] [Related]
17. Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes.
Wang L; Rolfe M; Proud CG
Biochem J; 2003 Jul; 373(Pt 2):603-11. PubMed ID: 12720544
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.
Yang TT; Xiong Q; Graef IA; Crabtree GR; Chow CW
Mol Cell Biol; 2005 Feb; 25(3):907-20. PubMed ID: 15657420
[TBL] [Abstract][Full Text] [Related]
19. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
[TBL] [Abstract][Full Text] [Related]
20. Extracellular receptor kinase and cAMP response element binding protein activation in the neonatal rat heart after perinatal cocaine exposure.
Sun LS; Quamina A
Pediatr Res; 2004 Dec; 56(6):947-52. PubMed ID: 15470197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
